Needham, MA (PRWEB) April 25, 2012
Bio-IT World announced the winners of its eighth Best Practices Awards competition this morning in a plenary session at the 2012 Bio-IT World Conference & Expo in Boston.
Grand Prize winners from five life sciences awards categories included entries from three big pharma companies—Merck, Pfizer, and Merck KGaA (Germany)—and two genomics organizations, BGI Shenzhen and the University of Utah/Omicia.
In addition, the Judges’ Prize was awarded to Bristol-Myer Squibb, while the Editors’ Choice Award was given to Elizabeth Worthey & her colleagues at the Medical College of Wisconsin for the Carpe Novo clinical genome analysis platform.
“We extend our sincere congratulations to the winners of this year’s Bio-IT World Best Practices Awards competition” said Kevin Davies, editor of Bio-IT World. “Our select judges enjoyed evaluating the dozens of excellent entries received this year, and believe that the contest has highlighted some truly innovative, game-changing tools and solutions. Our winners should be very proud that they have captured the imagination and respect of such a distinguished jury.”
The Bio-IT World’s Best Practices Awards program was established in 2003 by the editors of Bio-IT World to recognize organizations for their outstanding innovations and excellence in the use of technologies and novel business strategies that will advance biomedical and translational research, drug development, and/or clinical trials.
Bio-IT World’s Best Practices Awards ceremony was this morning at the World Trade Center in Boston. The awards presentations were co-hosted by Phillips Kuhl, co-founder and president of Cambridge Healthtech Institute (CHI), and Kevin Davies, editor-in-chief of Bio-IT World.
A panel of ten invited expert judges peer reviewed 47 detailed submissions from organizations ranging from large pharmaceutical and biotechnology companies to academic institutions and niche service providers around the world, detailing best practices in five categories as well as two special awards from the judges and the editors.
The Grand Prize trophies were presented to the following organizations within these categories:
Criteria and Judging
Awards finalists and winners were selected for their innovative use of bio-IT, including life science equipment, informatics, and information technology, on a project or organizational level to achieve significantly improved results (i.e. improvements in productivity or conceptual breakthroughs in scientific understanding or process methodology). The judges rated entries on several criteria, including innovation, importance, return on investment and likely industry impact, seeking stories that spotlighted the practical and positive deployment of novel technologies in academic, medical or commercial organizations. For further information on Bio-IT World’s Best Practices Awards, please email marketing_chmg(at)chimediagroup(dot)com.
The 2012 Best Practices Awards were organized by Bio-IT World managing editor Allison Proffitt and editor Kevin Davies. Joining the editors in judging the entries was a distinguished panel of experts:
The 2013 Bio-IT World Best Practices competition will begin soliciting entries in October 2012. Contact: Kevin Davies (Editor, Bio-IT World): email@example.com, 781-972-1341 or Allison Proffitt (Managing Editor, Bio-IT World): aproffitt(at)healthtech(dot)com.
About Bio-IT World
Part of the Cambridge Healthtech Institute Media Group (http://www.chimediagroup.com), Bio-IT World covers the application of informatics, IT and computer science in biomedical research and drug discovery. The web portal at bio-itworld.com provides topical news coverage and analysis of cutting-edge technologies to handle the data deluge in petascale computing and the tools to deliver individualized medicine. In addition, Cambridge Healthtech Media Group publishes a variety of e-newsletters, and hosts a rich compendium of webinars and web symposia.
About Cambridge Healthtech Institute (CHI)
Founded in 1992, Cambridge Healthtech Institute (http://www.chicorporate.com) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, academic, and niche service provider organizations. CHI’s integrated life science portfolio of products and services includes Cambridge Healthtech Institute Conferences, Pharmaceutical Strategy Series, Barnett International, Cambridge Healthtech Associates, Insight Pharma Reports, Marketing Services, Meeting Planners, and Cambridge Healthtech Media Group, which includes several eNewsletters, Bio-IT World.com, as well as Lead Generation Programs.